AMAG Pharmaceuticals Inc. (AMAG)
NASDAQ: Health Care
$13.90
0.35 | 2.58%
0.35 | 2.58%
Today's Range:
13.38 -
13.96
AMAG Avg. Daily Volume:
142,300
05/25/12 - 4:00 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 13.90 |
| 52 Week High | 19.62 |
| 52 Week Low | 12.43 |
| Avg. Daily Vol. (Mil) | 0.14 |
| Beta (3 year) | -0.35 |
| Share Related Items | |
| Mkt Cap (Mil) | 296.88 |
| Shares Out (Mil) | 21.36 |
| Float (Mil) | 14.46 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.50 |
| Current Ratio | 6.00 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 4.69 |
| Price/Book | 1.75 |
| Price/Cash Flow | -4.90 |
| Per Share Data | |
| Earnings | -3.16 |
| Sales | 2.97 |
| Book Value | 7.96 |
| Cash Flow | -2.87 |
| Business Summary | |
|---|---|
| A biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. | |
| General Information | |
| 100 Hayden Avenue
Lexington, MA 02421 |
|
| www.amagpharma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 174 | |
| CEO: Mr. Frank E. Thomas | |
| Short Interest | |
| Current Month (Mil) | 1.11 |
| Previous Month (Mil) | 1.03 |
| Short Interest Ratio (Days) | 6.50 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -26.50 |
| Return on Investments | -39.00 |
| Profitability | |
| Gross Margin | 93.40 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.26
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet